Ascentage Pharma Group International (OTCMKTS:ASPHF) Short Interest Up 12.1% in December

Ascentage Pharma Group International (OTCMKTS:ASPHF) saw a significant increase in short interest during the month of December. As of December 15th, there was short interest totalling 858,900 shares, an increase of 12.1% from the November 30th total of 766,100 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

Ascentage Pharma Group International Stock Performance

OTCMKTS ASPHF opened at $6.45 on Tuesday. Ascentage Pharma Group International has a fifty-two week low of $6.45 and a fifty-two week high of $6.45. The stock has a 50-day simple moving average of $6.45 and a two-hundred day simple moving average of $4.04.

Ascentage Pharma Group International Company Profile

Ascentage Pharma Group International, a clinical-stage biotechnology company, engages in developing therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in the United States and Mainland China. Its primary product HQP1351, a BCR-ABL inhibitor targeting BCR-ABL mutants, including those with the T315I mutation.